Method for treating a synucleiopathy
AssigneeAffiris AG
InventorsMarkus MANDLER, Petra Gruber, Frank Mattner, Walter Schmidt
Life of this patent
Estimating the term…
Abstract
A method for preventing and/or treating a synucleinopathy, comprising administering a composition containing at least one mimotope of an epitope of alpha-synuclein, wherein said at least one mimotope is coupled or fused to a pharmaceutically acceptable carrier protein selected from the group consisting of a non-toxic diphtheria toxin mutant, keyhole limpet hemocyanin (KLH), diphtheria toxin (DT), tetanus toxid (TT) and Haemophilus influenzae protein D (protein D).
Claims18
A method for treating a synucleinopathy comprising administering to a subject in need thereof an effective amount of at least one mimetope of an epitope of alpha-synuclein
- wherein said at least one mimotope is coupled or fused to a pharmaceutically acceptable carrier protein selected from the group consisting of a non-toxic diphtheria toxin mutant, keyhole limpet hemocyanin (KLH), diphtheria toxin (DT), tetanus toxid (TT) and Haemophilus influenzae protein D (protein D).
Dependencies are inferred from the claim text.